SERUM BIOMOLECULES AS POTENTIAL BIOMARKERS OF CLINICAL EFFICACY AND PREDICTORS OF RESPONSE TO BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTS

Luque-Tevar, M.Perez-Sanchez, C.Pilar, F. U.Romero-Gomez, M.Patino-Trives, A. M.Ruiz, D.Arias de la Rosa, I.Abalos-Aguilera, M. D. C.Ortega Castro, R.Escudero Contreras, A.Rodriguez-Escalera, C.Perez Venegas, J. J.Ruiz Montesinos, M. D.Dominguez, C.Romero Barco, C.Fernandez-Nebro, A.Mena-Vazquez, N.Marenco, J. L.Uceda, J.Toledo-Coello, M. D.Barbarroja Puerto, N.Aguirre, M. A.Lopez-Pedrera, C.Collantes-Estevez, E.2025-01-072025-01-072020-06-010003-4967https://hdl.handle.net/10668/25093enSERUM BIOMOLECULES AS POTENTIAL BIOMARKERS OF CLINICAL EFFICACY AND PREDICTORS OF RESPONSE TO BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTSconference outputopen access10.1136/annrheumdis-2020-eular.44421468-2060https://ard.bmj.com/content/annrheumdis/79/Suppl_1/951.2.full.pdf555905003117